Funding sources This study was supported by research funds from Dong-A University.
A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up
Article first published online: 13 JAN 2014
© 2013 British Association of Dermatologists
British Journal of Dermatology
Volume 170, Issue 1, pages 165–172, January 2014
How to Cite
Ko, D.Y., Kim, K.H. and Song, K.H. (2014), A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up. British Journal of Dermatology, 170: 165–172. doi: 10.1111/bjd.12627
Conflicts of interest None declared.
- Issue published online: 13 JAN 2014
- Article first published online: 13 JAN 2014
- Accepted manuscript online: 14 SEP 2013 08:07AM EST
- Manuscript Accepted: 3 SEP 2013
- Dong-A University
- 1Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis 1912; 30:241–55..
- 24A 24-month update of a placebo controlled European study comparing MAL-PDT with cryotherapy and 5-fluorouracil in patients with Bowen's disease. J Eur Acad Dermatol Venereol 2005; 19 (Suppl. 2):237–8., , et al.
- 28Photodynamic therapy for treatment of Bowen's disease. Korean J Dermatol 2007; 45:237–41., , , .
- 29Clinical responses to topical photodynamic therapy of actinic keratoses, Bowen's disease and non-oncological disease in Japan. Laser Therapy 2010; 19:159–66., , et al.
- 32In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolaevulinic acid application with enhancement using an erbium:YAG laser. J Pharm Sci 2006; 95:929–38., , et al.
- 33Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Exp Dermatol 2010; 19:806–12., , , .